Equities

Medfield Diagnostics AB

MEDF:AKT

Medfield Diagnostics AB

Actions
Health CareMedical Equipment and Services
  • Price (SEK)0.208
  • Today's Change-0.021 / -9.17%
  • Shares traded359.69k
  • 1 Year change-91.43%
  • Beta1.0073
Data delayed at least 15 minutes, as of Apr 18 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Medfield Diagnostics AB is a Sweden-based developer of medical instrumentation. The Company develops, markets and sells diagnostic instrumentation based on microwave technology. The Company's microwave technology complements other imaging principles in two main ways. Firstly microwaves sense dielectric properties and provide high contrast for biological matter with different water content, thus enabling diagnosis of for example blood in brain tissue or tumors in breast tissue. Secondly microwave instruments are compact and thus used earlier in the healthcare chain, in emergency rooms and in ambulances. The Company’s products include R10; the M100, available on stroke services for night-time surveillance of patients at increased risk of stroke, as well as D1000 that is a diagnostic instrument for use in emergency rooms and ambulances to diagnose the type of stroke, ischemic (blood clot) or hemorrhagic (bleeding).

  • Revenue in SEK (TTM)713.00k
  • Net income in SEK-15.02m
  • Incorporated2005
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Audientes A/S1.98m-21.02m5.00m11.00k--0.6795--2.52-0.3407-0.34070.02850.06770.0618-0.05370.6894115.09-65.40-47.21-155.90-64.67117.14---1,058.85-4,172.600.1708-6.570.0123--1,502.53--44.98------
Perpetua Medical AB (publ)9.94m-18.28m10.16m----0.7683--1.02-0.5927-0.59270.23220.12180.63786.603.78---117.31-83.52-164.97-102.1958.8563.46-183.94-250.302.14--0.0068---1.7657.204.63--8.89--
Qlife Holding AB244.00k-159.96m10.98m--------45.01-0.2636-0.26360.0003-0.02230.00211.540.2847---138.07---256.73---4,761.48---65,556.15--0.1683-19.45-----98.64---71.74------
S2Medical AB (publ)6.97m-22.71m11.49m----7.81--1.65-0.109-0.1090.04210.0060.29850.33485.24---97.24-65.16-520.37-101.5072.2665.03-325.74-220.190.1754-2.050.00--49.2736.0522.91---14.79--
Medfield Diagnostics AB713.00k-15.02m18.01m----0.2442--25.26-0.2513-0.25130.0120.92980.0093-1.880.5942---19.55-14.34-20.52-15.38765.78547.85-2,106.17-826.132.61-12.28-----70.29---79.42--3.75--
Medimi AB3.64m-14.25m22.65m6.00--1.59--6.23-0.0213-0.02130.00520.01320.18760.62284.68606,148.30-73.50-81.87-87.84-93.9356.054.06-391.85-840.934.14-134.590.1791--75.13280.697.52------
Invent Medic Sweden AB6.71m-8.53m26.11m8.00--5.08--3.89-0.2275-0.22750.17870.12810.68072.124.10838,421.30-86.60-97.56-123.70-121.0677.7677.16-127.22-490.981.05-21.440.3058--115.97177.5328.77---22.61--
ATTANA AB5.05m-13.83m31.04m----1.18--6.14-0.0468-0.04680.01690.06760.1626-0.54782.30---44.53-37.21-70.65-46.79134.99175.97-273.78-254.870.6238-8.710.1445---32.896.615.50--7.55--
Chordate Medical Holding AB (publ)976.29k-29.19m31.34m3.00--1.30--32.10-0.0955-0.09550.00320.04930.0481-0.21238.42325,430.00-143.79-91.98-223.15-122.85134.10209.52-2,989.55-3,295.751.60--0.00--799.630.6511-4.45------
Neodynamics AB (publ)321.00k-92.67m32.55m----0.1759--101.39-39.35-39.350.10235.670.00417.610.0245---117.68-53.18-146.30-61.85-13,815.58---28,867.60-17,683.520.6984-25.64----137.95---24.36---45.17--
Scandinavian ChemoTech AB2.82m-21.09m39.09m6.00--3.90--13.85-1.58-1.580.20940.6150.15430.32655.75470,333.30-115.35-87.29-168.57-118.5558.75252.05-747.38-2,122.770.8244-23.700.00--496.6219.137.28------
Scandinavian Real Heart AB902.89k-67.98m43.55m11.00--0.5309--48.23-0.7008-0.70080.01050.84580.0081--0.659582,080.91-61.12-24.27-72.47-26.81-60.31491.13-7,528.86-3,241.65----0.0914--35.2451.98-385.97--1.91--
VibroSense Dynamics AB2.08m-7.61m44.27m----4.42--21.31-0.5156-0.51560.13250.2920.18890.14419.78---69.18-46.24-85.81-53.0894.0285.61-366.26-551.223.09--0.00--22.8929.616.88---5.74--
Data as of Apr 18 2024. Currency figures normalised to Medfield Diagnostics AB's reporting currency: Swedish Krona SEK
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.